$GEHC Income Statement | Understand Stock

$GEHC

$71.98 +$0.53 (0.74%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
Revenues
Product
Service
Total revenues
Cost of sales
Product
Service
Gross profit
Selling, general, and administrative
Research and development
Total operating expenses
Operating income
Interest and other financial charges – net
Non-operating benefit (income) costs
Other (income) expense – net
Income from continuing operations before income taxes
Benefit (provision) for income taxes
Net income from continuing operations
Income (loss) from discontinued operations, net of taxes
Net income
Net (income) loss attributable to noncontrolling interests
Net income attributable to GE HealthCare
Deemed preferred stock dividend of redeemable noncontrolling interest
Net income attributable to GE HealthCare common stockholders
Earnings per share from continuing operations attributable to GE HealthCare common stockholders:
Basic (in dollars per share)
Diluted (in dollars per share)
Earnings per share attributable to GE HealthCare common stockholders:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted-average number of shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments